The pharmacokinetics of naftazone-3H
Delwaide, P.A.; Derouaux, G.; Heusghem, C.
Archives Internationales de Pharmacodynamie et de Therapie 208(2): 357-361
1974
ISSN/ISBN: 0003-9780 PMID: 4849939 Document Number: 75407
Document emailed within 1 workday
Related Documents
Bressolle, F.; Bres, J.; Brun, S.; Rechencq, E. 1979: Quantitative determination of drugs by in situ spectrophotometry of chromatograms for pharmacokinetic studies. I. Sulpiride and other benzamides, vincamine, naftazone Journal of Chromatography 174(2): 421-433Paxton, J.W. 1981: Elementary pharmacokinetics in clinical practice 4: genetic, environmental and age influences on pharmacokinetics New Zealand Medical Journal 94(697): 423-425
Brion, N.; Contrepois, A.; Carbon, C. 1983: From serum pharmacokinetics to extravascular pharmacokinetics of antibiotics. Importance of protein binding Presse Medicale 12(5): 293-296
Daniel, W.; Syrek, M.; Janczar, L.; Boksa, J. 1995: The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats--a comparison with the pharmacokinetics of imipramine Polish Journal of Pharmacology 47(2): 127-136
De Mey, C.; Scharpe, S.; De Bock, R.; Bossaert, L. 1981: Predictive pharmacokinetics of amikacin using actually measured and assumed parameters, applied in 1-compartment linear pharmacokinetics Archives Internationales de Pharmacodynamie et de Therapie 253(2): 323-324
Yamamoto, N.; Yanagi, K.; Matuyama, H.; Shimizu, K.; Mitsui, H.; Shimabukuro, T.; Yamamoto, M.; Sakatoku, J.; Fujita, T.; Matsuoka, K. 1987: Pharmacokinetics of high-dose cisplatin administration (relationship between pharmacokinetics and administration schedule) Hinyokika Kiyo. Acta Urologica Japonica 33(11): 1760-1765
Liu, M.J.; Brouwer, K.L.; Pollack, G.M. 1992: Pharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(6): 810-815
Pannuti, F.; Coppi, G.; Borella, F.; Martoni, A.; Urbano, L.; Melotti, B. 1988: Pharmacokinetics of PTT-119 in man Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 7(2): 113-116
Schoenwald, R.D.; Kumakura, T.; Catanese, B. 1987: Pharmacokinetics of benzydamine International Journal of Tissue Reactions 9(2): 93-97
Pfeifer, S. 1992: Pharmacokinetics in the aged Die Pharmazie 47(5): 319-332
Wildfeuer, A.; Lemme, J.D. 1985: The pharmacokinetics of josamycin Arzneimittel-Forschung 35(3): 639-643
Aarons, L. 1992: Population pharmacokinetics International Journal of Clinical Pharmacology Therapy and Toxicology 30(11): 520-522
Sergeeva, S.A.; Krasnykh, L.M. 1994: The pharmacokinetics of adamantanes Eksperimental'naia i Klinicheskaia Farmakologiia 57(3): 69-74
Schnyder, W.; Rudhardt, M.; Balant, L.; Fabre, J.; Estreicher, J. 1979: Pharmacokinetics of bacampicillin in man Schweizerische Rundschau für Medizin Praxis 68(3): 85-91
Pinheiro, R.L. 1992: Pharmacokinetics in the elderly Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(2): 191-197
Al-Tahan, F.; Löscher, W.; Frey, H.H. 1984: Pharmacokinetics of clonazepam in the dog Archives Internationales de Pharmacodynamie et de Therapie 268(2): 180-193
Setnikar, I.; Palumbo, R.; Canali, S.; Zanolo, G. 1993: Pharmacokinetics of glucosamine in man Arzneimittel-Forschung 43(10): 1109-1113
Oellerich, M.; Sybrecht, G.W. 1984: Pharmacokinetics of theophylline British Journal of Clinical Practice. Supplement 35: 3-4
Kalabukhova, N.F. 1973: Ampicillin pharmacokinetics Antibiotiki 18(5): 416-420
Abernethy, D.R.; Greenblatt, D.J.; Divoll, M.; Shader, R.I. 1983: Pharmacokinetics of alprazolam Journal of Clinical Psychiatry 44(8 Pt 2): 45-47